NCT03738137View on ClinicalTrials.gov

Narcotrend Versus Bispectral Index Monitoring During Sufentanil-Midazolam Anesthesia for Bronchoscopy

NACompletedINTERVENTIONAL
Enrollment

80

Participants

Timeline

Start Date

August 1, 2018

Primary Completion Date

January 15, 2019

Study Completion Date

January 30, 2019

Conditions
Bronchoscopy
Interventions
DEVICE

Narotrend

Narcotrend motoring

DEVICE

BIS

Bispectral index monitoring

DRUG

Sufentanil

sufentanil is applied.

DRUG

Lidocaine

Topical Anesthesia

DRUG

Midazolam

midazolam is applied.

Trial Locations (1)

510000

The First Affiliated Hospital of Guangzhou Medical University, Guangzhou

All Listed Sponsors
lead

Guangzhou Institute of Respiratory Disease

OTHER

NCT03738137 - Narcotrend Versus Bispectral Index Monitoring During Sufentanil-Midazolam Anesthesia for Bronchoscopy | Biotech Hunter | Biotech Hunter